RE: From the AGM25 Aug 2023 10:08
Whether he is nostradamus or not, let's give him a chance. He is a trader we know that but maybe just maybe he has some inside info that news is coming. I am willing to buy in and hope ... its been all hope with hemo and other people's predictions so why not buy in and wait a few weeks. I outline HH's post from feb and whether these have come true or not, in theory all this news is still possible and could land soon ....
"Recap of why so many of the LTHs are so excited and have their positions set. Its not about the minutia of the timing, its about the quality of the news when it comes
Updates from the #HEMO that we may see this year - I've added what my confidence level is for an update in 3mth to 6 mths (only my Opinion)
Timing is less clear - but its 25 days since the last RNS so we are due something soon with so much news anticipated
Anything I have missed ?
Are your confidence levels similar to mine?
1. IND Submission - confirming final step on pivotal transition to Clinical Biotech (99%)
2. Commencement of Human Trials (90%)
3. Confirmation of 1st Patient selected and dosed (90%)
4. Within 6-8 weeks, of dosing, initial findings of first patient - Tolerance and Efficacy (80%)
5. Details on #Hemo plans in Bioefense market (50%)
6. Multi-million dollar Biodefense grant (30%)
7. Further details on CBR proof of concept and next steps (80%)
8. TR1 - unveil new major or strategic shareholdings (50%)
9. Update on partnership for CBR - #Hemo already suggested they could work with multiple partners to take CBR
forwards on multiple fronts. (30%)
10. More details from #Hemo in regards to how the £4m recently raised will help them accelerate CAR-T and CBR drug candidates (80%)
11. Unveil plans to dual list and attract additional investment on NasDaq (20%)
12. Announce Investor day and/or Investor call + Vlad interviews (maybe with other leaders too?) (60%)
13. Announce receipt of offer from Big Pharma (Take over) - 10%
14. CDX Update (70%)
15, CBR fast tracked by FDA to cope with Covid (5%)"